Showing 1401-1410 of 1560 results for "".
- Pharmaceutical Executives Field Questions at US Senate Hearing Over Drug Pricinghttps://modernod.com/news/pharmaceutical-executives-field-questions-at-us-senate-hearing-over-drug-pricing/2476258/CEOs and senior executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson appeared before the US Senate Finance Committee on Tuesday to testify about the high cost of drugs in the country. The executives, who continued to blame pharmacy
- Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with J&J’s Janssenhttps://modernod.com/news/morphic-therapeutic-enters-into-integrin-research-and-development-collaboration-with-jjs-janssen/2476272/Morphic Therapeutic announced that it has entered into a research and development collaboration with Johnson & Johnson’s subsidiary Janssen Biotech, to discover and develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies. Johnson &a
- Janssen Enters License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseaseshttps://modernod.com/news/janssen-enters-license-agreement-with-meiragtx-to-develop-gene-therapy-programs-for-inherited-retinal-diseases/2476340/The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings, a clinical-stage gene therapy company, to develop, manufacture and commercialize its clinical stage inherited retinal disease portfolio, including leadin
- US House Oversight Committee Launches Investigation into Prescription Drug Pricinghttps://modernod.com/news/us-house-oversight-committee-launches-investigation-into-prescription-drug-pricing/2476191/The US House of Representatives’ Oversight Committee on Monday announced a probe into a dozen pharmaceutical companies regarding drug pricing. In the investigation, Representative and committee chairman Elijah Cummings sent letters to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson
- Two Studies Measure Performance of Acuvue Oasys with Transitions Light Intelligent Technology Contact Lenseshttps://modernod.com/news/two-studies-measure-performance-of-acuvue-oasys-with-transitions-light-intelligent-technology-contact-lenses/2479693/Johnson & Johnson Vision announced that data from two new studies on the visual effects of photochromic contact lenses were presented at the 2018 American Academy of Optometry Annual Meeting in San Antonio. These are the first scientific presentations focused on photochromic contact lens tech
- J&J Vision Introduces Artificial-Intelligence Powered Virtual Assistant for Contact Lenseshttps://modernod.com/news/jj-vision-introduces-artificial-intelligence-powered-virtual-assistant-for-contact-lenses/2480195/Johnson & Johnson Vision introduced Andy, a virtual assistant chatbot powered by artificial intelligence (AI). Andy is designed to help guide U.S. consumers throughout their Acuvue brand contact lens journey – from those considering contact lenses for the first time to long-term wearers. The
- John Kitchens, MDhttps://modernod.com/profiles/john-kitchens-md/jpd2Yj/John Kitchens is a retina specialist and partner at Retina Associates of Kentucky. John matched into residency at the acclaimed University of Iowa Department of Ophthalmology. During his time at Iowa, John won the American College of Eye Surgeons Bloomberg Video Competition for best resident cata…
- John Berdahlhttps://modernod.com/profiles/john-berdahl/OnmPXY/
- John Rajihttps://modernod.com/profiles/john-raji/LgyNMm/
- John Gelleshttps://modernod.com/profiles/john-gelles/j1eDmY/